Filing Details

Accession Number:
0001209191-14-066666
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-05 16:31:48
Reporting Period:
2014-10-31
Filing Date:
2014-11-05
Accepted Time:
2014-11-05 16:31:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1267602 Alimera Sciences Inc ALIM Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1489533 Daniel C. Myers 6120 Windward Parkway, Suite 290
Alpharetta GA 30005
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-10-31 460 $4.85 108,817 No 5 A Direct
Common Stock Disposition 2014-11-03 2,000 $5.35 106,817 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 A Direct
No 4 S Direct
Footnotes
  1. These shares were acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d).
  2. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2014.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.35 to $5.3563, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.